Cancers (Jul 2023)

Integrative Transcriptomic Profiling of the Wilms Tumor

  • Simona Lucija Avčin,
  • Klementina Črepinšek,
  • Barbara Jenko Bizjan,
  • Robert Šket,
  • Jernej Kovač,
  • Blaž Vrhovšek,
  • Jerca Blazina,
  • Olga Blatnik,
  • Robert Kordič,
  • Lidija Kitanovski,
  • Janez Jazbec,
  • Maruša Debeljak,
  • Tine Tesovnik

DOI
https://doi.org/10.3390/cancers15153846
Journal volume & issue
Vol. 15, no. 15
p. 3846

Abstract

Read online

Our study aimed to identify relevant transcriptomic biomarkers for the Wilms tumor, the most common pediatric kidney cancer, independent of the histological type and stage. Using next-generation sequencing, we analyzed the miRNA profiles of 74 kidney samples, which were divided into two independent groups: fresh frozen tissue and formalin-fixed paraffin-embedded tissue samples. Subsequent mRNA expression profiling and pathway analysis were performed to establish the interplay and potential involvement of miRNAs and mRNA in the Wilms tumor. Comparative analysis, irrespective of post-dissection tissue processing, revealed 41 differentially expressed miRNAs, with 27 miRNAs having decreased expression and 14 miRNAs having increased expression in the Wilms tumor tissue compared to healthy kidney tissue. Among global mRNA transcriptomic profile differences, cross-sectional analysis suggested a limited list of genes potentially regulated by differentially expressed miRNAs in the Wilms tumor. This study identified the comprehensive miRNA and mRNA profile of the Wilms tumor using next-generation sequencing and bioinformatics approach, providing better insights into the pathogenesis of the Wilms tumor. The identified Wilms tumor miRNAs have potential as biomarkers for the diagnosis and treatment of the Wilms tumor, regardless of histological subtype and disease stage.

Keywords